2024
Characterizing a syndemic: STI symptoms, substance use & violence among incarcerated Peruvian women
Hashemi E, Cyrus E, Turpin R, Bazo A, Morgan-Lopez A, Scheidell J, Leon S, Altice F, Sciaudone M, Dyer T. Characterizing a syndemic: STI symptoms, substance use & violence among incarcerated Peruvian women. European Journal Of Public Health 2024, 34: ckae144.1502. PMCID: PMC11517018, DOI: 10.1093/eurpub/ckae144.1502.Peer-Reviewed Original ResearchIncarcerated womenSubstance useInterpersonal violenceSexually transmitted infection symptomsIncreased rates of incarcerationSexually transmitted infectionsExperiences of interpersonal violenceRates of incarcerationSTI symptomsLatent profile analysisViolenceLatent classesAt-risk populationsIncarcerationPrisonPeruvian womenEpidemiological dataSexual behaviorSymptomsLogistic regressionWomenBivariate analysisLatent profile analysis modelSubstancesIncreased rate
2022
The Initial Response to COVID-19 Disruptions for Older People with HIV in Ukraine
Rozanova J, Rich K, Altice F, Shenoi S, Zaviryukha I, Kiriazova T, Mamedova E, Shipunov O, Yariy V, Deac A, Zeziulin O. The Initial Response to COVID-19 Disruptions for Older People with HIV in Ukraine. Geriatrics 2022, 7: 138. PMID: 36547274, PMCID: PMC9777936, DOI: 10.3390/geriatrics7060138.Peer-Reviewed Original ResearchGeneralised anxiety disorderSymptoms of depressionSymptoms of anxietyHIV treatmentSevere depressionOlder peopleMental healthActive drug useSubstance use disordersFirth logistic regression modelHigher suicidal ideationLogistic regression modelsIndependent correlatesUse disordersTelehealth strategiesDrug useSuicidal ideationSymptomsHIVAnxiety disordersSubstance useDepressionStandardised scalesCOVID-19 restrictionsInitial response
2018
Brief Report
Delaney JA, Nance RM, Whitney BM, Altice FL, Dong X, Trejo MEP, Matsuzaki M, Taxman FS, Chander G, Kuo I, Fredericksen R, Strand LN, Eron JJ, Geng E, Kitahata MM, Mathews WC, Mayer K, Moore RD, Saag MS, Springer S, Chandler R, Kahana S, Crane HM. Brief Report. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2018, 79: 283-287. PMID: 30036277, PMCID: PMC6681811, DOI: 10.1097/qai.0000000000001803.Peer-Reviewed Original ResearchConceptsPHQ-9 scoresDepressive symptomsSubstance useATS useLower oddsMean decreaseAmphetamine-type substancesAIDS Research NetworkCocaine/crack useDepressive symptom scoresMental health disordersJoint longitudinal-survival modelCocaine/crackPoor outcomeSymptom scoresPHQ-9Health disordersIllicit opiatesSymptomsPLWHLongitudinal assessmentSite cohortSubstance use frequencyCrack useAbstinenceA multisite, longitudinal study of risk factors for incarceration and impact on mental health and substance use among young transgender women in the USA
Hughto JMW, Reisner SL, Kershaw TS, Altice FL, Biello KB, Mimiaga MJ, Garofalo R, Kuhns LM, Pachankis JE. A multisite, longitudinal study of risk factors for incarceration and impact on mental health and substance use among young transgender women in the USA. Journal Of Public Health 2018, 41: 100-109. PMID: 29474682, PMCID: PMC6490767, DOI: 10.1093/pubmed/fdy031.Peer-Reviewed Original ResearchConceptsYoung transgender womenIllicit drug useRisk factorsTransgender womenRecent incarcerationDrug useSignificant independent predictorsIndividual risk factorsSubstance use disordersIndependent predictorsDepressive symptomsGeneral populationUse disordersMultilevel interventionsSomatic symptomsPoor healthRecent homelessnessMental healthStudy periodSubstance useWomenMixed effects modelsLongitudinal studySymptomsEffects model
2010
Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia
Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. International Journal Of STD & AIDS 2010, 21: 416-423. PMID: 20606222, PMCID: PMC2925151, DOI: 10.1258/ijsa.2009.009180.Peer-Reviewed Original Research
2009
Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market
Bruce RD, Govindasamy S, Sylla L, Kamarulzaman A, Altice FL. Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market. The American Journal Of Drug And Alcohol Abuse 2009, 35: 68-72. PMID: 19212931, PMCID: PMC2791788, DOI: 10.1080/00952990802585406.Peer-Reviewed Original ResearchConceptsBuprenorphine/naloxoneOpioid withdrawal symptomsSyringe sharingWithdrawal symptomsSnowball recruitment techniquesLogistic regression analysisDiversion of buprenorphineLack of reductionEvidence-based approachPrimary outcomeBuprenorphine injectionOnly symptomBenzodiazepine useBenzodiazepine injectionStomach painBuprenorphineInjection doseRisk behaviorsSymptomsNaloxoneInjectionRegression analysisNLXDaily amountDose
2008
Case Series of Buprenorphine Injectors in Kuala Lumpur, Malaysia
Bruce RD, Govindasamy S, Sylla L, Haddad MS, Kamarulzaman A, Altice FL. Case Series of Buprenorphine Injectors in Kuala Lumpur, Malaysia. The American Journal Of Drug And Alcohol Abuse 2008, 34: 511-517. PMID: 18584580, DOI: 10.1080/00952990802122259.Peer-Reviewed Original ResearchConceptsBuprenorphine injectionBuprenorphine injectorsCase seriesSignificant adverse health consequencesProspective cohort studyPossible pharmacological interactionsAdverse health consequencesDiversion of buprenorphineCohort studyResultant symptomsPoor outcomeCase reportTreatment modalitiesPharmacological interactionsBuprenorphineEuphoric effectsHealth consequencesKuala LumpurMidazolamInjectionQualitative interviewsSymptoms
1996
Albendazole-induced pseudomembranous colitis.
Shah V, Marino C, Altice FL. Albendazole-induced pseudomembranous colitis. The American Journal Of Gastroenterology 1996, 91: 1453-4. PMID: 8678015.Peer-Reviewed Original ResearchConceptsPseudomembranous colitisIntestinal microsporidiosisDifficile toxinPositive stool specimenC. difficile toxinClostridium difficile toxinAbdominal painOral vancomycinFlexible sigmoidoscopyPatient's symptomsCase reportStool specimenPathogenic mechanismsColitisAlbendazolePatientsSymptomsMetronidazoleAIDSMicrosporidiosisTreatmentToxinSigmoidoscopyPainDiarrhea